Meptid (Meptazinol)

Meptid is an opioid analgesic used to treat pain conditions that involve the central nociceptive pathway.

• Moderate acute pain: provides effective relief of pain that is of moderate intensity and short duration.
• Post‑operative pain: helps control pain after surgical procedures, facilitating early mobilization.
• Trauma‑related pain: reduces discomfort following injuries such as fractures or soft‑tissue damage.

• Meptazinol acts as a partial agonist at mu‑opioid receptors in the central nervous system. By binding to these receptors, it produces analgesia while generating a lower maximal opioid effect compared with full agonists, which can result in reduced incidence of typical opioid‑related adverse effects such as respiratory depression.

Meptid may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Dizziness: transient light‑headedness.
• Constipation: reduced bowel movements.
• Headache: mild cranial discomfort.
• Somnolence: feeling unusually sleepy.
• Dry mouth: reduced salivation.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing, especially in opioid‑naïve patients.
• Severe hypotension: marked drop in blood pressure.
• Allergic reactions: rash, pruritus, or anaphylaxis.
• Seizures: rare neurologic events.
• Dependence or withdrawal: potential with prolonged use.
• Hepatic dysfunction: abnormal liver enzymes.

Before prescribing Meptid, clinicians should consider patient‑specific factors and safety measures.

• Assess renal and hepatic function: adjust use if impairment is present.
• Avoid in patients with known hypersensitivity to meptazinol or other opioids.
• Use caution in the elderly: increased susceptibility to sedation and falls.
• Monitor for signs of respiratory depression, especially after surgery.
• Do not combine with other central nervous system depressants without supervision.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Meptid can interact with several drug classes; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

• Other opioids: additive respiratory depression.
• Benzodiazepines or barbiturates: profound CNS depression.
• Monoamine oxidase inhibitors (MAOIs): risk of serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole): may increase meptazinol levels.
• CYP3A4 inducers (e.g., rifampicin): may reduce efficacy.
• Anticholinergic agents: may exacerbate constipation.